Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children With Seasonal Allergies
- Study Title
- Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Female, Maleergies
- Teva Identifier
- BDP-AR-305
- ClinicalTrials.gov Identifier
- NCT01307319
- Study Status
- Completed
- Trial Condition(s)
- Seasonal Female, Maleergic Rhinitis | SAR
- Interventions
- Drug: BDP HFA | Drug: Placebo nasal aerosol
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 6 Years to 11 Years
- Trial Duration
- 03/01/2011 - 08/01/2011
- Phase
- Phase 3
